ARCHIVES

Also NIH unveils Roadmap initiatives, releases four RFAs; Director Zerhouni defends peer review before House, Senate oversight committees, seeks greater authority for trans-NIH initiatives.

This article is from The Cancer Letter archive.

Vol. 29 No. 36 | October 3, 2003

Download PDF Visit The Full Archive

Related Articles

DCT Board reluctantly Okays Resources Contracts Recompetition, $6 of $10 Million Competitively

April 1, 1977

Children of Male Cancer Survivors Have Highrt Risk of Birth Defects

February 25, 2011

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

January 16, 1998

The Cancer Letter Wins Investigative Reporting Award

June 8, 2001

OMB Backs Down, Releases New Construction Funds After Ruling They Are “Alteration, Renovation”

December 13, 1974

ASCO Lists Top 11 Advances In Clinical Cancer Research

December 30, 2005